|
1
|
Kumar M, Nanavati R, Modi TG and Dobariya
C: Oral cancer: Etiology and risk factors: A review. J Cancer Res
Ther. 12:458–63. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hussein AA, Helder MN, de Visscher JG,
Leemans CR, Braakhuis BJ, de Vet HCW and Forouzanfar T: Global
incidence of oral and oropharynx cancer in patients younger than 45
years versus older patients: A systematic review. Eur J Cancer.
82:115–127. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hogan BV, Peter MB, Shenoy HG, Horgan K
and Hughes TA: Surgery induced immunosuppression. Surgeon. 9:38–43.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kim R: Anesthetic technique and cancer
recurrence in oncologic surgery: Unraveling the puzzle. Cancer
Metastasis Rev. 36:159–177. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kurosawa S and Kato M: Anesthetics, immune
cells, and immune responses. J Anesth. 22:263–277. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang T, Fan Y, Liu K and Wang Y: Effects
of different general anaesthetic techniques on immune responses in
patients undergoing surgery for tongue cancer. Anaesth Intensive
Care. 42:220–227. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Plein LM and Rittner HL: Opioids and
immune system-friend or foe. Br J Pharmacol. 175:2717–2725. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Stollings LM, Jia LJ, Tang P, Dou H, Lu B
and Xu Y: Immune modulation by volatile anesthetics.
Anesthesiology. 125:399–411. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mahmoud M and Mason KP: Dexmedetomidine:
Review, update, and future considerations of pediatric
perioperative and periprocedural applications and limitations. Br J
Anaesth. 115:171–182. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Maud AS, Michel MR, Laura NH, Clements RM,
Anthony RA and Pieter C: Clinical pharmacokinetics and
pharmacodynamics of dexmedetomine. Clin Pharmacokinet. 56:893–913.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang XH, Bai Q, Lv MM, Fu HG, Dong TL and
Zhou Z: Effect of dexmedetomidine on immune function of patients
undergoing radical mastectomy. Eur Rev Med Pharmacol Sci.
21:1112–1116. 2017.PubMed/NCBI
|
|
12
|
Wang K and Li C: Effects of
dexmedetomidine on inflammatory factors, T lymphocyte subsets and
expression of NF-κB in peripheral blood mononuclear cells in
patients receiving radical surgery of colon carcinoma. Oncol Lett.
15:7153–7157. 2018.PubMed/NCBI
|
|
13
|
Wang Y, Xu X, Liu H and Ji F: Effects of
dexmedetomine on patients undergoing radical gastrectomy. J Surg
Res. 194:147–153. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mayhew D, Mendonca V and Murthy BVS: A
review of ASA physical status-historical perspectives and modern
developments. Anesthesia. 74:373–379. 2019. View Article : Google Scholar
|
|
15
|
Scott NW, McPherson GC, Ramsay CR and
Campbell MK: The method of minimization for allocation to clinical
trials: A review. Control Clin Trials. 23:662–674. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Barr J, Fraser GL, Puntillo K, Ely EW,
Gélinas C, Dasta JF, Davidson JE, Devlin JW, Kress JP, Joffe AM, et
al: Clinical practice guidelines for the management of pain,
agitation, and delirium in adult patients in the Intensive Care
Unit. Crit Care Med. 41:263–306. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen L, Jondal M and Yakimchuk K:
Regulatory effects of dexamethasone on NK and T cell immunity.
Inflammopharmacology. 26:1331–1338. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ebert TJ, Hall JE, Barnev JA, Uhrich TD
and Colinco MD: The effects of increasing plasma concentrations of
dexmedetomidine in humans. Anesthesiology. 93:382–394. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xiang H, Hu B, Li Z and Li J:
Dexmedetomine controls systemic cytokine levels through the
cholinergic anti-inflammatory pathway. Inflammation. 37:1763–1770.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Goldfarb Y, Sorski L, Benish M, Levi B,
Melamed R and Ben-Eliyahu S: Improving postoperative immune status
and resistance to cancer metastasis: A combined perioperative
approach of immunostimulation and prevention of excessive surgical
stress responses. Ann Surg. 253:798–810. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Steinman RM: Decisions about dendritic
cells: Past, present, and future. Annu Rev Immunol. 30:1–22. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mildner A and Jung S: Development and
function of dendritic cell subsets. Immunity. 40:642–656. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Den Brok MH, Nierkens S, Figdor CG, Ruers
TJ and Adema GJ: Dendritic cells: Tools and targets for antitumor
vaccination. Expert Rev Vaccines. 4:699–710. 2005. View Article : Google Scholar
|
|
24
|
Dai J, El Gazzar M, Li GY, Moorman JP and
Yao ZQ: Myeloid-derived suppressor cells: Paradoxical roles in
infection and immunity. J Innate Immun. 7:116–126. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tamadaho RSE, Hoerauf A and Layland LE:
Immunomodulatory effects of myeloid-derived suppressor cells in
diseases: Role in cancer and infections. Immunobiology.
223:432–442. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Marvel D and Gabrilovich DI:
Myeloid-derived suppressor cells in the tumor microenvironment:
Expect the unexpected. J Clin Invest. 125:3356–3364. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yang X, Li Z, Gao C and Liu R: Effect of
dexmedetomidine on preventing agitation and delirium after
microvascular free flap surgery: A randomized, double-blind,
control study. J Oral Maxillofac Surg. 73:1065–1072. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Riker RR, Shehabi Y, Bokesch PM, Ceraso D,
Wisemandle W, Koura F, Whitten P, Margolis BD, Byrne DW, Ely EW, et
al: Dexmedetomidine vs. midazolam for sedation of critically ill
patients: A randomized trial. JAMA. 301:489–499. 2009. View Article : Google Scholar : PubMed/NCBI
|
